• A study of a first generation capsule found its sensitivity for polyps 6 mm or greater to be 64 percent and its sensitivity for polyps 10mm or greater to be 73 percent. The capsule’s specificity for polyps 6mm or greater and 10mm or greater was 84 percent and 79 percent, respectively.
• The most recent study of a second generation capsule found sensitivity for polyps 6mm or greater to be 81 percent and 80 percent for polyps 10mm or greater. The capsule demonstrated specificity of 93 percent for polyps 6mm or greater and specificity of 97 percent for polyps 10mm or greater.
• The author concluded that capsule endoscopy may not be ready to take on a large role in population-based screening, but it has demonstrated significant technological advancement.
More articles on gastroenterology:
Boston Scientific sales hit $1.77B in Q1: 5 things to know
Gastroenterology special issue: “You are what you eat”
$43B by 2019: 6 key trends in the global endoscopy market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.